CHANDAN — Chandan Healthcare Income Statement
0.000.00%
- IN₹4.74bn
- IN₹5.19bn
- IN₹1.77bn
- 37
- 20
- 78
- 41
Annual income statement for Chandan Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 1,196 | 1,369 | 1,766 |
Cost of Revenue | |||
Gross Profit | 558 | 704 | 936 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Other Operating Expenses | |||
Total Operating Expenses | 1,193 | 1,296 | 1,537 |
Operating Profit | 2.94 | 72.9 | 229 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | -10.6 | 50.1 | 215 |
Provision for Income Taxes | |||
Net Income After Taxes | -10.9 | 35.9 | 164 |
Minority Interest | |||
Net Income Before Extraordinary Items | |||
Net Income | -11.1 | 33.7 | 163 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -11.1 | 33.7 | 163 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -0.454 | 1.38 | 6.66 |